Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Endocrinology|February 11, 2014
Oxytocin reverses ovariectomy-induced osteopenia and body fat gainGuillaume E Beranger, Didier F Pisani, Julien Castel, et al.
Journal of Clinical Medicine|March 29, 2020
Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial GrowthAndrea Gama, Laura Maman, Jorge William Vargas-Franco, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Oncotarget|December 6, 2018
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcomaSteven Georges, Lidia Rodriguez Calleja, Camille Jacques, et al.
Plos One|September 27, 2014
Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stabilityJean-Michel Davaine, Thibaut Quillard, Régis Brion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcomaAudrey Lamora, Julie Talbot, Gwenola Bougras, et al.
Cancer Research|October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation processGatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Bioconjugate Chemistry|May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of OsteosarcomaEmmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Cancers|October 26, 2018
The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung MetastasesBenjamin Navet, Kosei Ando, Jorge William Vargas-Franco, et al.
Frontiers in Immunology|August 6, 2019
Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological MechanismsCarla Alvarez, Gustavo Monasterio, Franco Cavalla, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Endocrinology|February 11, 2014
Oxytocin reverses ovariectomy-induced osteopenia and body fat gainGuillaume E Beranger, Didier F Pisani, Julien Castel, et al.
Journal of Clinical Medicine|March 29, 2020
Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial GrowthAndrea Gama, Laura Maman, Jorge William Vargas-Franco, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Oncotarget|December 6, 2018
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcomaSteven Georges, Lidia Rodriguez Calleja, Camille Jacques, et al.
Plos One|September 27, 2014
Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stabilityJean-Michel Davaine, Thibaut Quillard, Régis Brion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcomaAudrey Lamora, Julie Talbot, Gwenola Bougras, et al.
Cancer Research|October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation processGatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Bioconjugate Chemistry|May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of OsteosarcomaEmmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Cancers|October 26, 2018
The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung MetastasesBenjamin Navet, Kosei Ando, Jorge William Vargas-Franco, et al.
Frontiers in Immunology|August 6, 2019
Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological MechanismsCarla Alvarez, Gustavo Monasterio, Franco Cavalla, et al.
Pageof 25